Your browser doesn't support javascript.
loading
Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Houot, Roch; Bachy, Emmanuel; Cartron, Guillaume; Gros, François-Xavier; Morschhauser, Franck; Oberic, Lucie; Gastinne, Thomas; Feugier, Pierre; Duléry, Rémy; Thieblemont, Catherine; Joris, Magalie; Jardin, Fabrice; Choquet, Sylvain; Casasnovas, Olivier; Brisou, Gabriel; Cheminant, Morgane; Bay, Jacques-Olivier; Gutierrez, Francisco Llamas; Menard, Cédric; Tarte, Karin; Delfau, Marie-Hélène; Portugues, Cédric; Itti, Emmanuel; Palard-Novello, Xavier; Blanc-Durand, Paul; Al Tabaa, Yassine; Bailly, Clément; Laurent, Camille; Lemonnier, François.
Afiliação
  • Houot R; Department of Hematology, University Hospital of Rennes, UMR U1236, INSERM, University of Rennes, French Blood Establishment, Rennes, France. roch.houot@chu-rennes.fr.
  • Bachy E; Department of Hematology, Lyon Sud Hospital Center, INSERM U1111, Lyon, France.
  • Cartron G; Department of Hematology, University Hospital of Montpellier, UMR-CNRS 5535, Montpellier, France.
  • Gros FX; Department of Clinical Hematology and Cellular Therapy, University Hospital of Bordeaux, Bordeaux, France.
  • Morschhauser F; ULR 7365 - GRITA, University Hospital of Lille, Lille, France.
  • Oberic L; Department of Hematology, Cancer University Institute of Toulouse Oncopole, Toulouse, France.
  • Gastinne T; Department of Hematology, University Hospital of Nantes, Nantes, France.
  • Feugier P; Department of Hematology, University Hospital of Nancy, INSERM 1256, University of Lorraine, Vandœuvre-lès-Nancy, France.
  • Duléry R; Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMR938, Paris, France.
  • Thieblemont C; Department of Hematology and Oncology, Saint-Louis Hospital, AP-HP, Paris, France.
  • Joris M; Department of Hematology, University Hospital of Amiens, Amiens, France.
  • Jardin F; Department of Clinical Hematology, Henri Becquerel Center, INSERM U1245, Rouen, France.
  • Choquet S; Department of Hematology, University Hospital Pitié Salpêtrière, AP-HP, Sorbonne University, Paris, France.
  • Casasnovas O; Department of Clinical Hematology, Dijon University Hospital, INSERM UMR1231, Dijon, France.
  • Brisou G; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
  • Cheminant M; Department of Clinical Hematology, Necker-Enfants Malades University Hospital, AP-HP, INSERM UMR1163, Paris, France.
  • Bay JO; Department of Clinical Hematology and Cellular Therapy, Clermont-Ferrand University Hospital Center, Clermont-Ferrand, France.
  • Gutierrez FL; Department of Anatomopathology, University Hospital of Rennes, Rennes, France.
  • Menard C; French Blood Establishment and SITI Laboratory, UMR U1236, INSERM, University of Rennes, University Hospital Center of Rennes, Rennes, France.
  • Tarte K; French Blood Establishment and SITI Laboratory, UMR U1236, INSERM, University of Rennes, University Hospital Center of Rennes, Rennes, France.
  • Delfau MH; Department of Immunology, Henri Mondor Hospital, Créteil, France.
  • Portugues C; Department of Biostatistics, LYSARC, Lyon-Sud Hospital, Pierre-Bénite, France.
  • Itti E; Department of Nuclear Medicine, Henri Mondor Hospital, Créteil, France.
  • Palard-Novello X; Department of Nuclear Medicine, University of Rennes, CLCC Eugène Marquis, INSERM, Rennes, France.
  • Blanc-Durand P; Department of Nuclear Medicine, CHU H. Mondor, U-PEC, AP-HP, Créteil, France.
  • Al Tabaa Y; Scintidoc Nuclear Medicine Center, Clinique Clémentville, Montpellier, France.
  • Bailly C; Nantes-Angers Cancer Research Center CRCI2NA, University of Nantes, INSERM UMR1307, CNRS-ERL6075, Nantes, France.
  • Laurent C; Department of Pathology, Cancer University Institute of Toulouse Oncopole, CHU Toulouse, CRCT INSERM U1037, Toulouse, France.
  • Lemonnier F; Lymphoid Malignancies Unit, Henri Mondor Hospital, Mondor Institute for Biomedical Research, INSERM U955, University Paris-Est, Créteil, France.
Nat Med ; 30(7): 2089, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38745012
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França